Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGOS THERAPEUTICS INCARGS · Entity 167312 | Director | December 31, 2016 | January 04, 2017 |
| CareDx, Inc.CDNA · Entity 4344 | Director | October 04, 2022 | October 04, 2022 |
| Liquidia Technologies IncLQDA · Entity 145051 | Director | June 22, 2020 | June 23, 2020 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | Director | May 28, 2025 | May 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGOS THERAPEUTICS INC
Report date December 31, 2016 · Filed January 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 573 |
Reported balance
After 2016-12-31 transaction · row 1
1 source rowRow 1 · 2016-12-31 · Grant · Acquired 573 · Balance 573 F1: The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock.
CareDx, Inc.
Report date October 04, 2022 · Filed October 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,177 |
Reported balance
After 2022-10-04 transaction · row 1
1 source rowRow 1 · 2022-10-04 · Grant · Acquired 775 · Balance 58,177 F1: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
Liquidia Technologies Inc
Report date June 22, 2020 · Filed June 23, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.97 · Expires 2030-06-22 | Direct | 20,000 |
Reported balance
After 2020-06-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-22 · Grant · Acquired 20,000 · Balance 20,000 F1: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023.
iRhythm Holdings, Inc.
Report date May 28, 2025 · Filed May 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,288 |
Reported balance
After 2025-05-28 transaction · row 1
1 source rowRow 1 · 2025-05-28 · Grant · Acquired 1,358 · Balance 13,288 F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PROCTER & GAMBLE Co
Report date June 10, 2010 · Filed June 11, 2010
Section 16 reporting ended · disclosed 2010-06-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,690.143 |
Reported balance
Holding disclosure · report date 2010-06-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 46,690.143 F1: Total includes grant of dividend equivalents in the form of RSUs on November 16, 2009 and February 16, 2010, pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes grant of dividend equivalents in the form of RSUs on November 16, 2009 and February 16, 2010, pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.
Press Ganey Holdings, Inc.
Report date October 21, 2016 · Filed October 25, 2016
Section 16 reporting ended · disclosed 2016-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-10-21 transaction · row 1
1 source rowRow 1 · 2016-10-21 · Disposition to issuer · Disposed 28,770 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2018 Filed Jul 3, 2018 17:20 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.74 | $0.00 |
DisclosureSEC source: 0000899243-18-019260 · doc4.xml · derivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-06-20 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019. Read SEC document |
| June 20, 2018 Filed Jul 3, 2018 17:20 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019260 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,799 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019. Read SEC document |
| May 23, 2018 Filed Jun 6, 2018 17:34 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-015273 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,142 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), which represents a contingent right to receive shares of IRTC common stock. The RSUs fully vest on May 23, 2019. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:52 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 2,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-009491 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,799 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| January 02, 2018 Filed Jan 2, 2018 20:52 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 1,924 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-000156 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,578 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:05 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantOption to Purchase Common Stock · Derivative | 6,679 | Not disclosed Strike: $5.49 | Not disclosed |
DisclosureSEC source: 0000899243-17-026011 · doc4.xml · derivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,679 Underlying: Common Stock · 6,679 shares Expires 2024-11-09 F3 · security: Represents a stock option granted pursuant to the Exchange Offer (the "New Options"). F4 · derivative.exercise_price: The exercise price per share equals the closing price per share of the Company's common stock, as quoted by NASDAQ, on November 9, 2017. F2 · price: On November 8, 2017, pursuant to the offer by CareDx, Inc. (the "Company") to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended and supplemented on October 24, 2017 and November 9, 2017(the "Exchange Offer"), the Company cancelled a stock option for 10,948 shares granted to the reporting person on June 19, 2014. In exchange for such cancelled stock option, the reporting person received a new stock option for 6,679 shares. F5 · derivative.exercise_date: The New Options are scheduled to vest in three equal installments based upon the Company's achievement of certain performance goals as follows: (i) one third of the New Options vest upon the Company's determination, which has been reviewed by the Company's independent registered public accounting firm, that the Company has achieved $10 million of total cumulative sales of Allosure, its proprietary next-generation sequencing-based test to detect donor-derived, cell-free DNA after transplantation, commencing after the completion of the Exchange Offer, (ii) one third of the New Options vest upon the Company's determination, which has been reviewed by the Company's independent registered public accounting firm, that the Company has achieved quarterly revenues of at least $18.75 million for two consecutive fiscal quarters commencing after the completion of the Exchange Offer, F6 · derivative.exercise_date: (Continued from Footnote 5) and (iii) one third of the New Options vest in the event the closing sales price of the Company's common stock is at or above $5.00 per share, as quoted by NASDAQ, for 10 consecutive trading days after the completion of the Exchange Offer. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:05 UTC | CareDx, Inc. CDNA · Entity 4344 | Disposition to issuerOption to Purchase Common Stock · Derivative | 10,948 | Not disclosed Strike: $12.40 | Not disclosed |
DisclosureSEC source: 0000899243-17-026011 · doc4.xml · derivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,948 shares Expires 2024-06-19 F2 · price: On November 8, 2017, pursuant to the offer by CareDx, Inc. (the "Company") to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended and supplemented on October 24, 2017 and November 9, 2017(the "Exchange Offer"), the Company cancelled a stock option for 10,948 shares granted to the reporting person on June 19, 2014. In exchange for such cancelled stock option, the reporting person received a new stock option for 6,679 shares. F1 · derivative.exercise_date: The shares underlying the cancelled option were vested and immediately exercisable. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:52 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,713 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-023558 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,654 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 10:39 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantEmployee Stock Option (right to buy) · Derivative | 4,089 | $0.00 Strike: $41.04 | $0.00 |
DisclosureSEC source: 0000899243-17-018533 · doc4.xml · derivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Underlying: Common Stock · 4,089 shares Expires 2027-07-17 F2 · derivative.exercise_date: The option vests in thirty-six equal monthly installments beginning on August 17, 2017. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 10:39 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018533 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), which represents a contingent right to receive shares of IRTC common stock. The RSUs vest in three annual installments and shall fully vest on July 17, 2020. Read SEC document |
| July 13, 2017 Filed Jul 14, 2017 17:11 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 15,000 | $1.22 Strike: $1.22 | $18,300.00 |
DisclosureSEC source: 0000899243-17-018282 · doc4.xml · derivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-07-13 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on August 13, 2017 and the shares subject to the option shall vest monthly thereafter through July 13, 2018. Read SEC document |
| July 13, 2017 Filed Jul 14, 2017 17:11 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018282 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,941 F1 · shares: The reported securities are represented by restricted stock units which shall vest on July 13, 2018. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 18:11 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 7,534 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017850 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,941 F1 · shares: Represents an automatic, quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 17:58 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009313 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,407 F1 · shares: Represents an automatic, quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 19:44 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 3,463 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-000339 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,023 F1 · shares: Represents an automatic, quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 11:38 UTC | ARGOS THERAPEUTICS INC ARGS · Entity 167312 | GrantCommon Stock | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001178031-17-000001 · primary_doc.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573 F1 · shares: The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 12:07 UTC | ARGOS THERAPEUTICS INC ARGS · Entity 167312 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.90 | $0.00 |
DisclosureSEC source: 0001178031-16-000002 · primary_doc.xml · derivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-12-08 F1 · derivative.exercise_date: This option was granted on December 9, 2016 and vests in equal amounts quarterly over the next three years. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 15:44 UTC | Press Ganey Holdings, Inc. PGND · Entity 181517 | Disposition to issuerCommon Stock | 28,770 | $40.50 | $1,165,185.00 |
DisclosureSEC source: 0001179110-16-030914 · edgar.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 19:44 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-031005 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,560 F1 · shares: Represents an automatic, quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| June 17, 2015 Filed Jul 15, 2019 16:19 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 5,255 | $0.00 Strike: $5.85 | $0.00 |
DisclosureSEC source: 0000899243-19-019608 · doc4a.xml · derivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,255 Underlying: Common Stock · 5,255 shares Expires 2025-06-17 F1 · derivative.exercise_price: This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4. F1 · date: This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4. F1 · price: This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4. F1 · derivative.exercise_date: This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4. F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 17, 2015 and 1/12th of the shares subject to the option shall vest monthly thereafter. F1 · derivative.expiration_date: This amendment is being filed to correct the transaction date, exercise price, date exercisable, expiration date and price of derivative security of the Stock Option (right to buy) reported on the original Form 4. Read SEC document |
| October 13, 2009 Filed Oct 15, 2009 17:19 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-020721 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,477.71 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs since February 17, 2009, pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| December 09, 2008 Filed Dec 10, 2008 15:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-010833 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,977.409 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on November 14, 2008, pursuant to Issuer's 2003 Non-Employee Direc tors' Stock Plan. Read SEC document |
| October 14, 2008 Filed Oct 15, 2008 19:49 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 1,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-008171 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,306.211 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| September 16, 2008 Filed Sep 18, 2008 15:05 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-007077 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,355.211 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on August 15, 2008, pursuant to Issuer's 2003 Non-Employee Dir ectors' Stock Plan. Read SEC document |
| June 10, 2008 Filed Jun 11, 2008 17:50 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 443 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-004148 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,830.343 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividends equivalents in the form of RSUs on 5/15/2008 pursuant to Issuer's 2001 Stock Incentive Compensation Plan. Read SEC document |
| March 11, 2008 Filed Mar 13, 2008 14:05 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 503 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-001924 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,324.223 Read SEC document |
| February 06, 2008 Filed Feb 7, 2008 21:04 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,030 | $0.00 Strike: $41.97 | $0.00 |
DisclosureSEC source: 0001127602-08-000786 · form4.xml · derivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2008-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2008 Filed Feb 7, 2008 21:04 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 4,030 | $41.97 | $169,152.00 |
DisclosureSEC source: 0001127602-08-000786 · form4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,766.918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2007 Filed Dec 13, 2007 12:23 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-07-000272 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,736.918 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on November 15, 2007, pursuant to Issuer's 2003 Non-Employee Dir ectors' Stock Plan. Read SEC document |
| October 09, 2007 Filed Oct 11, 2007 13:08 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-07-000220 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,286.916 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| September 11, 2007 Filed Sep 12, 2007 21:02 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-07-000174 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,527.916 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on August 15, 2007, pursuant to Issuer's 2003 Non-Employee Direc tors' Stock Plan. Read SEC document |
| June 12, 2007 Filed Jun 14, 2007 19:53 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-07-000099 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,044.66 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on May 15, 2007, pursuant to Issuer's 2003 Non-Employee Director s' Stock Plan. Read SEC document |
| March 13, 2007 Filed Mar 15, 2007 14:08 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-07-000056 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,590.43 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on Nov. 15, 2006 and Feb. 15, 2007, pursuant to Issuer's 2003 No n-Employee Directors' Stock Plan. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 20:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (right to buy) · Derivative | 4,030 | $29.88 Strike: $29.88 | $120,403.50 |
DisclosureSEC source: 0000080424-07-000019 · doc4.xml · derivative · entry 3 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2007-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 20:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 4,030 | $64.43 | $259,653.30 |
DisclosureSEC source: 0000080424-07-000019 · doc4.xml · nonDerivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,104.367 F1 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on Nov. 15, 2006, pursuant to Issuer's 2003 Non-Employee Directo rs' Stock Plan. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 20:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 4,030 | $29.88 | $120,403.50 |
DisclosureSEC source: 0000080424-07-000019 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,134.367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2006 Filed Dec 14, 2006 14:34 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-06-000195 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,104.37 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs on Nov. 15, 2006, pursuant to Issuer's 2003 Non-Employee Directo rs' Stock Plan. Read SEC document |
| October 10, 2006 Filed Oct 12, 2006 19:27 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 2,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-06-000170 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,635.48 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| September 12, 2006 Filed Sep 13, 2006 20:40 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 473 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-06-000135 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,631.48 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs on August 15, 2006, pursuant to Issuer's 2003 Non-Employee Direc tors' Stock Plan. Read SEC document |
| June 13, 2006 Filed Jun 15, 2006 18:51 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-06-000082 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,126.11 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs on May 15, 2006, pursuant to Issuer's 2003 Non-Employee Director s' Stock Plan. Read SEC document |
| March 14, 2006 Filed Mar 16, 2006 20:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-06-000057 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,591.82 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs on February 15, 2006, pursuant to Issuer's 2003 Non-Employee Dir ectors' Stock Plan. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 21:32 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (right to buy) · Derivative | 4,030 | $20.30 Strike: $20.30 | $81,793.69 |
DisclosureSEC source: 0000080424-06-000019 · doc4.xml · derivative · entry 3 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2006-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 21:32 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 4,030 | $59.59 | $240,147.70 |
DisclosureSEC source: 0000080424-06-000019 · doc4.xml · nonDerivative · entry 2 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,075.71 Read SEC document |
| February 13, 2006 Filed Feb 15, 2006 21:32 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 4,030 | $20.30 | $81,793.69 |
DisclosureSEC source: 0000080424-06-000019 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,105.71 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2005 Filed Dec 15, 2005 19:21 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-05-000264 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,075.71 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs on November 15, 2005, pursuant to Issuer's 2003 Non-Employee Dir ectors' Stock Plan. Read SEC document |
| October 11, 2005 Filed Oct 13, 2005 18:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 2,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-05-000213 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,608.69 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| September 13, 2005 Filed Sep 15, 2005 19:54 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-05-000155 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,381.69 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. F2 · balance_after: Total reflects grant of dividend equivalents in the form of RSUs between February 17, 2004 and August 15, 2005, pursuant to Issue r's 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| June 14, 2005 Filed Jun 16, 2005 20:07 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 392 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000080424-05-000081 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,861 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 19:24 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-05-000035 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,469 F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan. Read SEC document |
| December 20, 2004 Filed Jan 5, 2005 19:14 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GiftCommon Stock | 2,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-05-000001 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,997 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.